Wells Fargo raised the firm’s price target on Constellation Brands (STZ) to $165 from $160 and keeps an Overweight rating on the shares. The firm notes Q3 was ahead of expectations, marked by beats on Beer depletions and margins. As argued in Wells’ 2026 Staples Year Ahead, Constellation is one of the more intriguing controversial recovery stories at lows, the firm argues, adding that this “certainly keeps the intrigue alive.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STZ:
- Constellation Brands: Inventory Risks, Margin Pressures, and Still-Rich Valuation Support Continued Sell Rating
- Closing Bell Movers: Defense stocks surge on Trump military budget comments
- STZ Earnings: Constellation Brands’ Financial Results Top Wall Street Estimates
- Constellation Brands Posts Q3 Declines, Maintains Dividend Payout
- Constellation Brands backs FY26 comparable EPS view $11.30-$11.60
